NCT06284057Recruiting
Lower Silesia Culotte Bifurcation Registry (LSCBR).
Double Kissing (DK) vs Culotte Culotte. Lower Silesia Culotte Bifurcation Registry (LSCBR).
Source: ClinicalTrials.gov · Last updated 6 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study aimed to evaluate the outcomes of bifurcation PCI using two techniques (Culotte vs. DK-Culotte) using data from a retrospective analysis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 21 Feb 2024
- Start date
- 1 Apr 2013
- Primary completion date
- 1 Apr 2028
- Lead sponsor
- Miedziowe Centrum Zdrowia SA
- Diseases
- Coronary artery disease
- NCT number
- NCT06284057
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Apr 2013 to the primary completion date, 1 Apr 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who underwent PCI with coronary stents prior to the index procedure for the bifurcation lesion studied.
Who the study is looking for
- Presence of significant changes in the coronary bifurcation requiring the implantation of two coronary stents using the Culotte or DK Culotte technique.
Age in the registry: 18 years to - · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology, Provincial Specialized Hospital in Legnica Coordinator of this site? Confirm its status | Legnica | Poland | Recruiting |
| Department of Cardiology, The Copper Health Centre (MCZ) Coordinator of this site? Confirm its status | Lubin | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.